Report cover image

Respiratory Inhalers Market by Product Type (Dry Powder Inhaler, Metered Dose Inhaler, Nebulizer), Age Group (Adults, Pediatric), Mode, Disease Indication, End-Use - Global Forecast 2024-2030

Publisher 360iResearch
Published Jan 15, 2024
Length 188 Pages
SKU # IRE18449673

Description

Respiratory Inhalers Market by Product Type (Dry Powder Inhaler, Metered Dose Inhaler, Nebulizer), Age Group (Adults, Pediatric), Mode, Disease Indication, End-Use - Global Forecast 2024-2030


The Respiratory Inhalers Market size was estimated at USD 2.96 billion in 2023 and expected to reach USD 3.24 billion in 2024, at a CAGR 9.74% to reach USD 5.68 billion by 2030.

Global Respiratory Inhalers Market

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Respiratory Inhalers Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Respiratory Inhalers Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Respiratory Inhalers Market, highlighting leading vendors and their innovative profiles. These include AstraZeneca PLC, Beximco Pharmaceuticals Ltd., C.H. Boehringer Sohn Ko. KG, Cadila Healthcare Ltd., Chiesi Farmaceutici S.p.A., Cipla Limited, GlaxoSmithKline PLC, Heltman Medikal A.S., Koninklijke Philips N.V., Lupin Limited, Merck & Co., Inc., Microlife Corporation, Novartis AG, Opko Health, Inc., Rossmax International Ltd., and Teva Pharmaceutical Industries Ltd..

Market Segmentation & Coverage



This research report categorizes the Respiratory Inhalers Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product Type
Dry Powder Inhaler
Metered Dose Inhaler
Nebulizer
Soft Mist Inhalers
Age Group
Adults
Pediatric
Mode
Digitally Operated Devices
Manually Operated Devices
Disease Indication
Asthma
Chronic Obstructive Pulmonary Disease
Pulmonary Arterial Hypertension
End-Use
Clinics & Hospitals
Pharmacies
Respiratory Care Center
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Respiratory Inhalers Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Respiratory Inhalers Market?
3. What are the technology trends and regulatory frameworks in the Respiratory Inhalers Market?
4. What is the market share of the leading vendors in the Respiratory Inhalers Market?
5. Which modes and strategic moves are suitable for entering the Respiratory Inhalers Market?

Note: PDF & Excel + Online Access - 1 Year

Table of Contents

188 Pages
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Respiratory Inhalers Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rise in air pollution rate worldwide and occurrence of respiratory disorders
5.1.1.2. Increasing consumer awareness of pulmonary disorders
5.1.1.3. Growing government focus on improving asthma care
5.1.2. Restraints
5.1.2.1. Stringent regulations for inhaler approvals by the government
5.1.3. Opportunities
5.1.3.1. Introduction of innovative smart inhalers
5.1.3.2. Development of effective inhaler medication formulations
5.1.4. Challenges
5.1.4.1. Incorrect usage and operational issues in inhalers
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Respiratory Inhalers Market, by Product Type
6.1. Introduction
6.2. Dry Powder Inhaler
6.3. Metered Dose Inhaler
6.4. Nebulizer
6.5. Soft Mist Inhalers
7. Respiratory Inhalers Market, by Age Group
7.1. Introduction
7.2. Adults
7.3. Pediatric
8. Respiratory Inhalers Market, by Mode
8.1. Introduction
8.2. Digitally Operated Devices
8.3. Manually Operated Devices
9. Respiratory Inhalers Market, by Disease Indication
9.1. Introduction
9.2. Asthma
9.3. Chronic Obstructive Pulmonary Disease
9.4. Pulmonary Arterial Hypertension
10. Respiratory Inhalers Market, by End-Use
10.1. Introduction
10.2. Clinics & Hospitals
10.3. Pharmacies
10.4. Respiratory Care Center
11. Americas Respiratory Inhalers Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Respiratory Inhalers Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Respiratory Inhalers Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.2. Market Share Analysis, By Key Player
14.3. Competitive Scenario Analysis, By Key Player
15. Competitive Portfolio
15.1. Key Company Profiles
15.1.1. AstraZeneca PLC
15.1.2. Beximco Pharmaceuticals Ltd.
15.1.3. C.H. Boehringer Sohn Ko. KG
15.1.4. Cadila Healthcare Ltd.
15.1.5. Chiesi Farmaceutici S.p.A.
15.1.6. Cipla Limited
15.1.7. GlaxoSmithKline PLC
15.1.8. Heltman Medikal A.S.
15.1.9. Koninklijke Philips N.V.
15.1.10. Lupin Limited
15.1.11. Merck & Co., Inc.
15.1.12. Microlife Corporation
15.1.13. Novartis AG
15.1.14. Opko Health, Inc.
15.1.15. Rossmax International Ltd.
15.1.16. Teva Pharmaceutical Industries Ltd.
15.2. Key Product Portfolio
16. Appendix
16.1. Discussion Guide
16.2. License & Pricing
FIGURE 1. RESPIRATORY INHALERS MARKET RESEARCH PROCESS
FIGURE 2. RESPIRATORY INHALERS MARKET SIZE, 2023 VS 2030
FIGURE 3. RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. RESPIRATORY INHALERS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. RESPIRATORY INHALERS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. RESPIRATORY INHALERS MARKET DYNAMICS
FIGURE 7. RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
FIGURE 8. RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2023 VS 2030 (%)
FIGURE 10. RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2023 VS 2030 (%)
FIGURE 12. RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2023 VS 2030 (%)
FIGURE 14. RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
FIGURE 16. RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS RESPIRATORY INHALERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. AMERICAS RESPIRATORY INHALERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES RESPIRATORY INHALERS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 20. UNITED STATES RESPIRATORY INHALERS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC RESPIRATORY INHALERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC RESPIRATORY INHALERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 25. RESPIRATORY INHALERS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 26. RESPIRATORY INHALERS MARKET SHARE, BY KEY PLAYER, 2023

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us